| generic | brand | pharmacological category | common indication | essential knowledge |
| testosterone gel (topical) | Androgel, Fortesta, Vogelxo | Androgen | hypogonadism | Key Side Effects: contact dermatitis, acne, increased prostate specific antigen (PSA), emotional lability, hypertension
US Boxed Warnings: secondary exposure may result in virilization (especially in children); CI in males with breast or prostate cancer |
| alendronate (PO) | Fosamax | bisphosphonate | osteoporosis | Key Side Effects: dyspepsia, gastroesophageal reflux disease, hypocalcemia, atypical fractures, osteonecrosis of the jaw
Other Notes: CI in patients with abnormalities of the esophagus; administer ≥30 minutes before food or drink (except plain water); re |
| ibandronate(PO,IV) | Boniva | Bisphosphonate | osteoporosis | Key Side Effects: dyspepsia, gastroesophageal reflux disease, hypocalcemia, atypical fractures, osteonecrosis of the jaw
Other Notes (oral only): CI in patients with abnormalities of the esophagus; administer ≥60 minutes before food or drink (except plai |
| raloxifene (PO) | Evista | selective estrogen receptor modulator (SERM) | osteoporosis, breast cancer prevention | Key Side Effects: hot flashes, leg cramps, peripheral edema, arthralgia
US Boxed Warnings: increased risk of thromboembolism; increased risk of death caused by stroke in patients with cardiovascular disease |
| sildenafil (PO) | viagra, revatio | phosphodiesterase-5 enzyme (PDE-5) inhibitor | ED, PAH | Key Side Effects: priapism, headache, flushing, visual disturbance
Other Notes: CI with concomitant use of nitrates (may cause severe hypotension) |
| tadalafil (PO) | cialis | phosphodiesterase-5 enzyme (PDE-5) inhibitor | ED, BPH | Key Side Effects: priapism, headache, flushing, visual disturbance
Other Notes: CI with concomitant use of nitrates (may cause severe hypotension) |
